Bibliographie (2546)
3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval
lundi, 22 février 2021 03:14 Écrit par Zouhair SouissiNews Release: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval – The Lancet Original study: Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials – […]
The post 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval appeared first on Links Medicus.
Fauci: There’s evidence COVID-19 vaccines don’t just protect you — they may stop you from spreading the virus to others, too
vendredi, 19 février 2021 05:09 Écrit par Zouhair SouissiFauci: There’s evidence COVID-19 vaccines don’t just protect you — they may stop you from spreading the virus to others, too – Insider Related: [Preprint] Covid-19 vaccination associated with reduced viral load, may reduce transmission (study and commentary)
The post Fauci: There’s evidence COVID-19 vaccines don’t just protect you — they may stop you from spreading the virus to others, too appeared first on Links Medicus.
Review: Oxygen administration for patients with ARDS
vendredi, 19 février 2021 05:09 Écrit par Zouhair SouissiOxygen administration for patients with ARDS – Journal of Intensive Care
The post Review: Oxygen administration for patients with ARDS appeared first on Links Medicus.
COVID‐19 convalescent plasma: Interim recommendations from the AABB
vendredi, 19 février 2021 05:09 Écrit par Zouhair SouissiCOVID‐19 convalescent plasma: interim recommendations from the AABB – Transfusion News release: AABB panel issues interim recommendations for Covid-19 convalescent plasma use
The post COVID‐19 convalescent plasma: Interim recommendations from the AABB appeared first on Links Medicus.
How many people get ‘long COVID’ – and who is most at risk?
vendredi, 19 février 2021 05:09 Écrit par Zouhair SouissiHow many people get ‘long COVID’ – and who is most at risk? – The Conversation
The post How many people get ‘long COVID’ – and who is most at risk? appeared first on Links Medicus.
A single dose of the Pfizer–BioNTech vaccine is 92.6% effective in preventing Covid-19. Is delaying the second dose to get more people vaccinated an alternative?
vendredi, 19 février 2021 05:09 Écrit par Zouhair SouissiSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine – New England Journal of Medicine Commentary: Researchers urge delaying Pfizer vaccine’s second dose as first highly effective – Reuters
The post A single dose of the Pfizer–BioNTech vaccine is 92.6% effective in preventing Covid-19. Is delaying the second dose to get more people vaccinated an alternative? appeared first on Links Medicus.
What does 95% COVID-19 vaccine efficacy really mean?
vendredi, 19 février 2021 05:09 Écrit par Zouhair SouissiWhat does 95% COVID-19 vaccine efficacy really mean? – The Lancet Infectious Diseases Related: Pfizer vaccine: what an ‘efficacy rate above 90%’ really means – The Conversation
The post What does 95% COVID-19 vaccine efficacy really mean? appeared first on Links Medicus.
Covid-19: In vitro studies show Pfizer-BioNTech and Moderna vaccines produce fewer antibodies against South African variant
vendredi, 19 février 2021 05:09 Écrit par Zouhair SouissiStudy 1: Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report – New England Journal of Medicine Study 2: Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report – New England Journal of Medicine Commentaries: Expert reaction to two NEJM Correspondence articles on in vitro studies of the Pfizer-BioNTech and Moderna vaccines and different variants/mutations […]
The post Covid-19: In vitro studies show Pfizer-BioNTech and Moderna vaccines produce fewer antibodies against South African variant appeared first on Links Medicus.
M-A: The effect of convalescent plasma therapy on COVID-19 patient mortality
jeudi, 18 février 2021 07:37 Écrit par Zouhair SouissiThe Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis – Mayo Clinic Proceedings Related study (not published yet) with conflicting results: RECOVERY trial: No Benefit from convalescent plasma in hospitalized patients with Covid-19 (news release and commentary)
The post M-A: The effect of convalescent plasma therapy on COVID-19 patient mortality appeared first on Links Medicus.
RCT: Vitamin D3 does not improve outcomes in hospitalized patients with moderate to severe COVID-19
jeudi, 18 février 2021 07:37 Écrit par Zouhair SouissiEffect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial – JAMA Editorial: Vitamin D3 to Treat COVID-19: Different Disease, Same Answer In this RCT a single high dose of #vitaminD3 (100K IU) raised mean serum 25OH D levels but had […]
The post RCT: Vitamin D3 does not improve outcomes in hospitalized patients with moderate to severe COVID-19 appeared first on Links Medicus.
